(S1 (S (S (NP (NP (NP (JJ Cdk-inhibitory) (NN activity)) (CC and) (NP (NN stability))) (PP (IN of) (NP (NN p27Kip1)))) (VP (VBP are) (ADVP (RB directly)) (VP (VBN regulated) (PP (IN by) (NP (JJ oncogenic) (NN tyrosine) (NNS kinases)))))) (. .)))
(S1 (S (S (NP (NN p27Kip1)) (VP (VBZ controls) (NP (NN cell) (NN proliferation)) (PP (IN by) (S (VP (VP (VBG binding) (PP (TO to))) (CC and) (VP (VBG regulating) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (JJ cyclin-dependent) (NNS kinases)) (PRN (-LRB- -LRB-) (NP (NN Cdks)) (-RRB- -RRB-))))))))))) (. .)))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN Cdk) (NN inhibition)) (CC and) (NP (NN p27) (NN stability))) (VP (VBP are) (VP (VBN regulated) (PP (IN through) (NP (NP (JJ direct) (NN phosphorylation)) (PP (IN by) (NP (NN tyrosine) (NNS kinases))))))))))) (. .)))
(S1 (S (S (NP (NP (NP (DT A) (VBN conserved) (NN tyrosine) (NN residue)) (PRN (-LRB- -LRB-) (NP (NN Y88)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ Cdk-binding) (NN domain)) (PP (IN of) (NP (NN p27)))))) (VP (MD can) (VP (VB be) (VP (VBN phosphorylated) (PP (IN by) (NP (DT the) (NP (NP (NN Src-family) (NN kinase) (NN Lyn)) (CC and) (NP (DT the) (NN oncogene) (NN product))) (NN BCR-ABL))))))) (. .)))
(S1 (S (S (NP (NN Y88) (NN phosphorylation)) (VP (VBZ does) (RB not) (VP (VB prevent) (NP (NP (NN p27) (NN binding)) (PP (TO to) (NP (NN cyclin) (NN A/Cdk2))))))) (. .)))
(S1 (S (ADVP (RB Instead)) (, ,) (NP (PRP it)) (VP (VBZ causes) (NP (NP (JJ phosphorylated) (NN Y88)) (CC and) (NP (NP (DT the) (JJ entire) (JJ inhibitory) (NN 3-LRB-10-RRB--helix)) (PP (IN of) (NP (NN p27))) (S (VP (TO to) (VP (VB be) (VP (VBN ejected) (PP (IN from) (NP (DT the) (NN Cdk2) (JJ active) (NN site))))))))) (, ,) (S (ADVP (RB thus)) (VP (VBG restoring) (NP (JJ partial) (NN Cdk) (NN activity))))) (. .)))
(S1 (S (S (ADVP (RB Importantly)) (, ,) (NP (DT this)) (VP (VBZ allows) (S (NP (JJ Y88-phosphorylated) (NN p27)) (VP (TO to) (VP (VB be) (ADVP (RB efficiently)) (VP (VBN phosphorylated) (PP (IN on) (NP (NN threonine) (CD 187))) (PP (IN by) (NP (NP (NN Cdk2)) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VBZ promotes) (NP (PRP$ its) (JJ SCF-Skp2-dependent) (NN degradation))))))))))))) (. .)))
(S1 (S (S (NP (NP (DT This) (JJ direct) (NN link)) (PP (IN between) (NP (NP (NN transforming) (NN tyrosine) (NNS kinases)) (CC and) (NP (NN p27))))) (VP (MD may) (VP (VB provide) (NP (NP (DT an) (NN explanation)) (PP (PP (IN for) (NP (NP (NN Cdk) (NN kinase) (NNS activities)) (VP (VBN observed) (PP (IN in) (NP (NN p27) (NNS complexes)))))) (CC and) (PP (IN for) (NP (NP (JJ premature) (NN p27) (NN elimination)) (PP (IN in) (NP (NP (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN transformed) (PP (IN by) (NP (VBN activated) (NN tyrosine) (NNS kinases))))))))))))))))) (. .)))
